CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ -- NamponsTM, the leading consumer brand for the treatment of nosebleeds, is expanding its retail availability with the launch of its popular NamponsTM and ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive ...

Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, spoke to the current state of research on revakinagene taroretcel ...

The approval of revakinagene taroretcel (Encelto; Neurotech) addresses a significant unmet need for patients with macular ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.

Mirian's condition, Ataxia-Telangiectasia, impacts her nervous and immune systems, creating mobility and ongoing health challenges. Her family has set up a GoFundMe campaign to raise $15,000 for a ...

Mirian's condition, Ataxia-Telangiectasia, impacts her nervous and immune systems, creating mobility and ongoing health challenges. Her family has set up a GoFundMe campaign to raise $15,000 for a ...

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder.

SCOTTSDALE, Ariz., March 04, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and ...

1.Charbel Issa P, Gillies MC, Chew EY, Heeren TFC, Bird AC, Peto T, Holz FG, Scholl HPN (2013) Macular Telangiectasia Type 2. La Merie Publishing offers the service of preparing customized reports ...